196 related articles for article (PubMed ID: 21094859)
1. Astilbin suppresses acute heart allograft rejection by inhibiting maturation and function of dendritic cells in mice.
Zou S; Shen X; Tang Y; Fu Z; Zheng Q; Wang Q
Transplant Proc; 2010 Nov; 42(9):3798-802. PubMed ID: 21094859
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z
Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187
[TBL] [Abstract][Full Text] [Related]
3. NK026680 inhibits T-cell function in an IL-2-dependent manner and prolongs cardiac allograft survival in rats.
Shibasaki S; Yamashita K; Goto R; Oura T; Wakayama K; Hirokata G; Shibata T; Igarashi R; Haga S; Ozaki M; Todo S
Transpl Immunol; 2012 Jan; 26(1):42-9. PubMed ID: 22019622
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin or tacrolimus alone fails to resist cardiac allograft accelerated rejection mediated by alloreactive CD4(+) memory T cells in mice.
Liang H; Liao C; Qi Z; Sha C; Xie B; Chen J; Xia J; Wang Y; Yao Q; Zhao Y
Transpl Immunol; 2010 Feb; 22(3-4):128-36. PubMed ID: 19755159
[TBL] [Abstract][Full Text] [Related]
5. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
Li J; Xia J; Zhang K; Xu L
J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive effects of DTCM-G, a novel inhibitor of the mTOR downstream signaling pathway.
Shibasaki S; Yamashita K; Goto R; Wakayama K; Tsunetoshi Y; Zaitsu M; Igarashi R; Haga S; Ozaki M; Umezawa K; Todo S
Transplantation; 2013 Feb; 95(4):542-50. PubMed ID: 23269193
[TBL] [Abstract][Full Text] [Related]
7. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
[TBL] [Abstract][Full Text] [Related]
8. Pitavastatin suppresses acute and chronic rejection in murine cardiac allografts.
Suzuki J; Koga N; Kosuge H; Ogawa M; Haraguchi G; Maejima Y; Saiki H; Isobe M
Transplantation; 2007 Apr; 83(8):1093-7. PubMed ID: 17452900
[TBL] [Abstract][Full Text] [Related]
9. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation.
Harrison PC; Mainolfi E; Madwed JB
J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853
[TBL] [Abstract][Full Text] [Related]
11. Immune tolerance of skin allograft transplantation induced by immature dendritic cells of a third party carrying donor antigens in mice.
Xin H; Yang W; Wang Q; You B; Tong Y; Peng Y
Transplant Proc; 2013 Mar; 45(2):552-7. PubMed ID: 23498791
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic insights into achievement of cardiac allograft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus.
Tao R; Wang L; Chen CH; Wang SH; Demarco RA; Lotze MT; Thai NL; Fung JJ; Lu L; Qian S
J Heart Lung Transplant; 2006 Mar; 25(3):310-9. PubMed ID: 16507425
[TBL] [Abstract][Full Text] [Related]
13. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors.
Antonysamy MA; Fanslow WC; Fu F; Li W; Qian S; Troutt AB; Thomson AW
J Immunol; 1999 Jan; 162(1):577-84. PubMed ID: 9886435
[TBL] [Abstract][Full Text] [Related]
15. Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin.
Ueki S; Yamashita K; Aoyagi T; Haga S; Suzuki T; Itoh T; Taniguchi M; Shimamura T; Furukawa H; Ozaki M; Umezawa K; Todo S
Transplantation; 2006 Dec; 82(12):1720-7. PubMed ID: 17198266
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of program death-1 in T cells has mild impact on allograft survival.
Chen L; Hussien Y; Hwang KW; Wang Y; Zhou P; Alegre ML
Transpl Int; 2008 Jan; 21(1):21-9. PubMed ID: 18076633
[TBL] [Abstract][Full Text] [Related]
18. Enhanced cardiac allograft survival by Vav1-Rac signaling blockade in a mouse model.
Wang S; Diao H; Guan Q; Jevnikar AM; Du C
Transpl Immunol; 2007 Jul; 18(1):53-61. PubMed ID: 17584603
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
Tanaka M; Mokhtari GK; Balsam LB; Cooke DT; Kofidis T; Zwierzchonievska M; Robbins RC
J Heart Lung Transplant; 2005 Apr; 24(4):446-53. PubMed ID: 15797747
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressants suppressing signal 2 of T-cell activation enable CsA to induce operational transplantation tolerance in a strongly immunogenic heart allograft model in rats.
Lin Y; Goebels J; Vandeputte M; Waer M
Transplant Proc; 1996 Apr; 28(2):977-8. PubMed ID: 8623485
[No Abstract] [Full Text] [Related]
[Next] [New Search]